- Home
- OPBK vs RNAC Comparison
OPBK vs RNAC Comparison
Compare OPBK & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPBK
- RNAC
- Stock Information
- Founded
- OPBK 2005
- RNAC 2007
- Country
- OPBK United States
- RNAC United States
- Employees
- OPBK N/A
- RNAC N/A
- Industry
- OPBK Major Banks
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- OPBK Finance
- RNAC Health Care
- Exchange
- OPBK Nasdaq
- RNAC Nasdaq
- Market Cap
- OPBK 204.6M
- RNAC 204.6M
- IPO Year
- OPBK 2018
- RNAC 2016
- Fundamental
- Price
- OPBK $13.17
- RNAC $7.49
- Analyst Decision
- OPBK Buy
- RNAC Strong Buy
- Analyst Count
- OPBK 2
- RNAC 4
- Target Price
- OPBK $16.50
- RNAC $40.50
- AVG Volume (30 Days)
- OPBK 41.9K
- RNAC 154.5K
- Earning Date
- OPBK 10-23-2025
- RNAC 11-06-2025
- Dividend Yield
- OPBK 3.63%
- RNAC N/A
- EPS Growth
- OPBK 13.19
- RNAC N/A
- EPS
- OPBK 1.58
- RNAC N/A
- Revenue
- OPBK $87,081,000.00
- RNAC $1,091,000.00
- Revenue This Year
- OPBK $22.24
- RNAC N/A
- Revenue Next Year
- OPBK $10.31
- RNAC N/A
- P/E Ratio
- OPBK $8.36
- RNAC N/A
- Revenue Growth
- OPBK 10.57
- RNAC N/A
- 52 Week Low
- OPBK $10.43
- RNAC $5.98
- 52 Week High
- OPBK $18.57
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- OPBK 45.00
- RNAC 36.81
- Support Level
- OPBK $12.93
- RNAC $7.15
- Resistance Level
- OPBK $13.44
- RNAC $7.74
- Average True Range (ATR)
- OPBK 0.22
- RNAC 0.66
- MACD
- OPBK 0.00
- RNAC -0.02
- Stochastic Oscillator
- OPBK 38.32
- RNAC 50.87
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.